NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









VirTech Bio

VirTech Bio

Private
Natick, MassachusettsHealthcare & Life Scienceshttps://virtechbio.com/

Last Round

VC Round

Dec 1, 2022

Total Funding Raised

$18.41M

Company Overview

VirTech Bio is a biotechnology company that develops a proprietary hemoglobin-based oxygen carrier (HBOC) solution for applications such as severe blood loss and organ preservation for transplants.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Medical Devices, Defense Tech

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

hemoglobin-based oxygen carrierHBOCblood substituteartificial bloodorgan preservationex vivo organ perfusionhemorrhagic shocktrauma carepolymerized hemoglobinmilitary medicineorgan transplantveterinary blood substituteresearch reagentorganoid culture

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VirTech Bio Comparables

Compare VirTech Bio with similar companies based on industry and business-model similarity.

VirTech Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HbO2 Therapeutics
87%
KaloCyte, Inc.
87%
OxyVita Inc.
83%

VirTech Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 1, 2022
SeedNov 1, 2022
GrantAug 1, 2021

VirTech Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 114% MoM.

  • May 1, 2025

    Monthly visitors increased 120% MoM, reaching 1.3K.

VirTech Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

VirTech Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VirTech Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersNatick, Massachusetts
Employee Range6
Year Founded2013
Last FundingDec 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.